Financials
- Market Capitalization 4.43 M
- Employee 15
- Founded 2021
- CEO N/A
- Website www.fibrobiologics.com
- Headquarter Delaware, United States
- FIGI BBG01K4MB400
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5005 | LIMN Liminatus Pharma, Inc. - Class A Common Stock | 0.10 USD | -9.09% | -28.57% | -16.67% | -98.36% | 4.49 M USD | ||
| 5006 | CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 0.36 USD | +2.86% | -5.26% | +5.88% | -77.64% | 4.61 M USD | ||
| 5022 | EVGN Evogene Ltd. - Ordinary Shares | 0.46 USD | 0.00% | +4.55% | -19.30% | -64.06% | 4.01 M USD | ||
| 5029 | SXTP 60 Degrees Pharmaceuticals, Inc. - Common Stock | 1.45 USD | 0.00% | -18.54% | +1.40% | -30.29% | 3.86 M USD |
Frequently asked questions about FibroBiologics, Inc. - Common Stock
What is the FibroBiologics, Inc. - Common Stock stock price today?
The current price of FibroBiologics, Inc. - Common Stock (FBLG) is 0.85. Over the past 24 hours, the stock has changed by -1.16%. Follow the FBLG chart for real-time price dynamics.
What is the stock ticker of FibroBiologics, Inc. - Common Stock?
FibroBiologics, Inc. - Common Stock trades under the ticker FBLG. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is FibroBiologics, Inc. - Common Stock stock going up?
FBLG has changed by -1.16% over the last week, -7.61% over the last month, and +30.77% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was FibroBiologics, Inc. - Common Stock net income for the last quarter?
FibroBiologics, Inc. - Common Stock reported net income of -5 M for the last quarter. The previous quarter showed -3.24 M, which means net income changed by -54.13%.
How many employees does FibroBiologics, Inc. - Common Stock have?
As of the latest available data, FibroBiologics, Inc. - Common Stock has 15 employees. Workforce size can provide additional context about the company's scale and operations.
What is FibroBiologics, Inc. - Common Stock EBITDA?
FibroBiologics, Inc. - Common Stock EBITDA is -2.39 M, and its EBITDA margin is -91.79%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy FibroBiologics, Inc. - Common Stock stock?
You can buy FibroBiologics, Inc. - Common Stock (FBLG) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in FibroBiologics, Inc. - Common Stock stock?
Investing in FibroBiologics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FBLG chart and related analysis on metatrader.com as part of your research.